Intuitive Surgical, Inc.
NasdaqGS-ISRG
Company Overview
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Name
Intuitive Surgical, Inc.
CEO
Dr. Gary S. Guthart Ph.D.
Website
www.intuitive.com
Sector
Health Care Equipment and Supplies
Year Founded
1995
Profile
Market Cap
$174.62B
EV
$169.95B
Shares Out
355.35M
Revenue
$7,572.5M
Employees
13,676
Margins
Gross
66.86%
EBITDA
31.51%
Operating
25.79%
Pre-Tax
29.46%
Net
27.65%
FCF
5.54%
Returns (5Yr Avg)
ROA
12.46%
ROTA
14.46%
ROE
14.32%
ROCE
14.4%
ROIC
19.76%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$483.95
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$4,757.2M
Net Debt
-$4,757.2M
Debt/Equity
0.01
EBIT/Interest
—
Growth (CAGR)
Rev 3Yr
13.62%
Rev 5Yr
13.39%
Rev 10Yr
14.06%
Dil EPS 3Yr
9.24%
Dil EPS 5Yr
11.5%
Dil EPS 10Yr
15.71%
Rev Fwd 2Yr
14.87%
EBITDA Fwd 2Yr
17.67%
EPS Fwd 2Yr
15.85%
EPS LT Growth Est
17.84%
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—